These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6133351)

  • 1. Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy.
    van Kammen DP; Mann LS; Sternberg DE; Scheinin M; Ninan PT; Marder SR; van Kammen WB; Rieder RO; Linnoila M
    Science; 1983 May; 220(4600):974-7. PubMed ID: 6133351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.
    Sedvall G; Fyrö B; Nybäck H; Wiesel FA; Wode-Helgodt B
    J Psychiatr Res; 1974; 11():75-80. PubMed ID: 4461807
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy.
    van Kammen DP; van Kammen WB; Mann LS; Seppala T; Linnoila M
    Arch Gen Psychiatry; 1986 Oct; 43(10):978-83. PubMed ID: 3753162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations.
    Maas JW; Bowden CL; Miller AL; Javors MA; Funderburg LG; Berman N; Weintraub ST
    Schizophr Bull; 1997; 23(1):147-54. PubMed ID: 9050120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
    Houston JP; Maas JW; Bowden CL; Contreras SA; McIntyre KL; Javors MA
    Psychiatry Res; 1986 Nov; 19(3):207-14. PubMed ID: 3797547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Tolerance" to neuroleptic-induced CSF HVA rise in schizophrenic patients in relation to clinical response.
    Joseph MH; Waddington JL
    Psychiatry Res; 1982 Aug; 7(1):133. PubMed ID: 6127745
    [No Abstract]   [Full Text] [Related]  

  • 9. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid homovanillic acid and hypokinetic side effects of neuroleptics.
    Bowers MB
    Psychopharmacology (Berl); 1985; 85(2):184-6. PubMed ID: 2861619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological studies on schizophrenia with special reference to homovanillic acid concentration in cerebrospin fluid.
    Shimizu T
    Bull Osaka Med Sch; 1979 Jul; 25(1):51-68. PubMed ID: 540184
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures.
    van Kammen DP; Kelley ME; Gilbertson MW; Gurklis J; O'Connor DT
    Am J Psychiatry; 1994 Mar; 151(3):372-8. PubMed ID: 8109645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid.
    Doran AR; Boronow J; Weinberger DR; Wolkowitz OM; Breier A; Pickar D
    Neuropsychopharmacology; 1987 Dec; 1(1):25-32. PubMed ID: 3509912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
    Massarotti M; Migliore A; Roccella P; Toffano G
    Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.
    Bowers MB; Heninger GR
    Psychiatry Res; 1981 Jun; 4(3):285-90. PubMed ID: 6115436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
    Boronow J; Pickar D; Ninan PT; Roy A; Hommer D; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1985 Mar; 42(3):266-71. PubMed ID: 2579616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients.
    Fyrö B; Wode-Helgodt B; Borg S; Sedvall G
    Psychopharmacologia; 1974 Mar; 35(4):287-94. PubMed ID: 4831513
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 19. CSF dopamine beta-hydroxylase in schizophrenia.
    Sternberg DE; van Kammen DP; Lerner P; Ballenger JC; Marder SR; Post RM; Bunney WE
    Arch Gen Psychiatry; 1983 Jul; 40(7):743-7. PubMed ID: 6134515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
    Sternberg DE; VanKammen DP; Lerner P; Bunney WE
    Science; 1982 Jun; 216(4553):1423-5. PubMed ID: 6124036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.